Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsJun Shimizu, Tatsuo Shioda, Yuka Yoshimura et al.|Scientific Reports|2022Cited by 48
Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsJun Shimizu, Tatsuo Shioda, Tadahiro Sasaki et al.|Scientific Reports|2023Cited by 0